What Are Clinical Trials?
Clinical trials are research studies involving people.
They test ways to treat and prevent cancer.
All of today’s standard cancer treatments are a result of clinical trials completed many years ago.
Who Organizes a Clinical Trial?
Organizations or individuals looking for better treatments for cancer or new ways to prevent or detect cancer may sponsor clinical trials. Individual doctors at cancer centers or other medical institutions can also conduct trials.
The National Cancer Institute sponsors numerous clinical trials covering a variety of cancers.
Other sponsors include drug makers, technology companies and groups like the American Cancer Society.
Each trial has a person in charge, usually a doctor, who is called the protocol chair or principal investigator (also called the PI).
Before enrolling in a trial, ask whether the trial has been approved by an Institutional Review Board or IRB. IRBs exist at most hospitals to help safeguard patient rights.
How Are Clinical Trials Conducted?
Clinical trials testing new treatments are carried out in phases.
Phase I — Is the Treatment Safe?
As the first step in testing the research, doctors gather information about the side effects of the treatment and decide on the safe dose. Only a few patients in a few places take part in a Phase I trial.
Phase II — Does the Treatment Work?
In this step, doctors test the treatment to see how well it works. Most of the time, fewer than 100 patients are involved in Phase II trials.
Phase III — Is the Treatment Better?
Phase III trials compare the new treatment against the current standard therapy and randomly assign patients into one of the two groups. Many people from all over the country take part in these trials.
Phase IV — Are There Better Ways to Use the Treatment?
In this final step, treatments are tested to make sure they are safe and work well over a long period of time. This phase most often occurs once the new treatment has been approved for standard use. Anywhere from several hundred to several thousand people are enrolled in a Phase IV trial.
Where Are Clinical Trials Conducted?
Clinical trials are available through oncologists everywhere — not just in major cities or in large hospitals.
Clinical trials take place in teaching hospitals, outpatient clinics, community hospitals and doctors’ offices.
What Are the Types of Clinical Trials?
Prevention
These trials test new approaches that doctors believe may reduce your chance of developing cancer. Most involve healthy people who have not had cancer. Some studies are conducted with people who have had cancer in the past to try to find ways to prevent second cancers.
Screening
Since cancer is often easier to cure when it is found early, screening trials test methods to better detect cancer, especially in the early stages. These studies also help find out whether finding cancer before it causes symptoms will lessen a patient’s chances of dying from the disease.
Diagnostic
Diagnostic trials help answer whether or not there are new approaches that could be used to find certain types of cancer and at an earlier stage.
Treatment
The purpose of these trials is to find out if a new treatment or technique is better than the standard treatment. This can include new approaches to radiation therapy, new drugs, vaccines and different combinations of treatment.
Supportive Care/Quality of Life
These studies explore ways to improve the comfort and quality of life of people with cancer or survivors. These trials also study ways to better combat the side effects of some treatments.
Genetics Studies
These are generally done with another clinical trial and focus on how genetic makeup can affect detection, diagnosis or response to cancer treatment.
Who Can Participate in a Clinical Trial?
Each clinical trial calls for certain criteria that a patient must meet to be included in that trial.
Your age, gender, medical history, current health, what type and stage of cancer all factor into eligibility.
It’s important to remember that clinical trials are completely voluntary. Patients can leave a trial at any time.
Informed consent is the process by which you agree to take part in a clinical trial after receiving information about the purpose of the study, the treatment that will be given, the tests that will be taken, and the risks and benefits of treatment.
You must sign a written consent form before being enrolled into a clinical trial. This form says that you understand the study and agree to take part.
What Are the Benefits?
Although there are risks with any treatment, there are also many benefits of taking part in a clinical trial. For example:
Access to promising new treatments that are not available outside of the clinical trial setting.
The treatment being studied may be better than the standard approach.
You are followed very closely by a research team that is made up of doctors and other health professionals.
You may be the first to benefit from the new method. Results from the study may help others in the future.
What Are the Risks?
Although there are risks with any treatment, there are also many benefits of taking part in a clinical trial. For example:
Access to promising new treatments that are not available outside of the clinical trial setting.
The treatment being studied may be better than the standard approach.
You are followed very closely by a research team that is made up of doctors and other health professionals.
You may be the first to benefit from the new method. Results from the study may help others in the future.
Questions to Ask Your Doctor
Before joining a clinical trial, you may want to ask your doctor questions about the study and your treatment.
What are you trying to learn from the study?
What do doctors know already about the treatments being studied?
What treatments and tests will I get during this trial?
Who will be in charge of my care during the study?
What are the differences between what I would get on this treatment and the standard treatment you would recommend?
What are the benefits and risks?
How will this affect my daily life?
How long will the study last?
What will I be asked to pay?
How will I know if the study was successful?
How Can I Join a Clinical Trial?
If you are interested in joining a clinical trial, talk to your doctor. He or she can help you find out if a trial is right for you.
The National Cancer Institute can give you information on current trials.
Who Pays for a Clinical Trial?
Before taking part in a clinical trial, it’s important to ask what your costs will be.
In some cases, the sponsor of the study (such as the government, drug makers or technology companies) will provide the new treatment at no cost and pay for any special testing or extra doctor visits. Some sponsors may pay more than this, such as covering travel time and mileage expenses. However, other trials may pay very little of your treatment costs.
If you have private insurance, check with your provider before you begin treatment. It may be willing to pay for some or all of the costs of your treatment, depending on the type of trial.
Medicare will pay for the routine costs for some government sponsored clinical trials. Ask your doctor or call your local Medicare provider to find out what Medicare will pay for your treatment.
Facts About Clinical Trials
More than 25,000 cancer patients enroll each year in clinical trials through the National Cancer Institute. Many more patients are enrolled in clinical trials sponsored by other groups.
About 60 percent of the adults enrolled in clinical trials are women.
Lung, breast, prostate and colon cancers have the highest number of clinical trials dedicated to them — more than 40 percent of the total number of trials.
Only a small percentage of all cancer patients enroll in clinical trials. Their participation may benefit them as well as future cancer patients.
Cancer Type Trial ID Description Notes
Brain Cancer BN012 Comparing radiation before surgery to radiation after surgery for patients with brain metastases Your doctor may recommend this study for treatment of brain cancer
Breast Cancer BR007 “DEBRA” De-escalating Breast Radiation After Lumpectomy for Low Risk, Estrogen Receptor Positive, Breast Cancer Your doctor may recommend this study during breast cancer treatment
Head and Neck Cancer RTOG 1216 Comparing 3 different drug regimens for head and neck cancer getting radiation and chemotherapy after surgery (Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab) Your doctor may recommend this study following surgery for a cancer of the mouth, throat or voicebox
HN005 De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Your doctor may recommend this study during treatment for oropharyngeal cancer
ECOG EA3161 Study of Maintenance Nivolumab vs. Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive Oropharyngeal Carcinoma (OPCA) Your doctor may recommend this study during treatment for oropharyngeal cancer
MNPR301 Testing a new mouth rinse to reduce mucositis during oropharyngeal cancer treatment Your doctor may recommend this study during treatment for oropharyngeal cancer
Lung Cancer S1827 “MAVERICK” Testing whether the use of brain scans alone Instead of brain scans plus preventive brain radiation affects lifespan in patients with small cell lung cancer Your doctor may recommend this study during lung cancer treatment
SBRT2 Testing whether a new method of measuring breathing is effective during focused lung radiation Your doctor may recommend this study during lung cancer treatment
LU002 Examining the benefit of adding SBRT for oligometastatic NSCLC Your doctor may recommend this study during lung cancer treatment
LU007 “RAPTOR” Testing if adding radiation to the immunotherapy drug atezolizumab for patients with extensive stage small cell lung cancer (ES-SCLC) can improve survival over atezolizumab alone Your doctor may recommend this study during lung cancer treatment
MK7337 Testing a new drug regimen to see if it improves survival for locally advanced NSCLC Your doctor may recommend this study during lung cancer treatment
SWOG1914 Studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer Your doctor may recommend this study during lung cancer treatment
Prostate Cancer GU009 Using a genomic test to personalize the hormone therapy given with radiation for high-risk prostate cancer Your doctor may recommend this study during prostate cancer treatment
SWOG1802 Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer Your doctor may recommend this study during metastatic prostate cancer treatment
Chart last updated November 2023.